Chia-Te Liao

18th September 2026 Friday

Time Session
18:00
19:00
Mini‑Oral Presentation 1 - Group B
Jia-Jin ChenTaiwan Moderator From AKI to AKD: Recovery Pathways and High-Risk PhenotypesAcute kidney disease (AKD) represents a critical transition between acute kidney injury (AKI) and chronic kidney disease. Drawing on real-world evidence from cardiac surgery, acute decompensated heart failure, and ECMO cohorts, this talk will illustrate how kidney recovery trajectories and AKD phenotypes identify patients at high risk for long-term kidney and cardiovascular events. It will also discuss opportunities to improve post-AKI care, including earlier resumption of RAAS inhibitors and emerging evidence for GLP-1 receptor agonists and SGLT2 inhibitors. Recognizing AKD may help transform post-AKI care from passive observation toward proactive cardiorenal risk management.
Rolando Claure-Del GranadoBolivia Moderator Practical Steps to Train (and Become) an AI-Era PhysicianArtificial intelligence is rapidly becoming part of everyday medicine, yet many physicians remain uncertain about how to begin using it effectively and responsibly. Becoming an “AI-era physician” does not require advanced technical expertise; it requires curiosity, critical thinking, and practical skills that can be progressively incorporated into clinical, academic, and research activities. In this Meet the Experts session, participants will explore concrete approaches to developing AI literacy, improving prompting skills, critically evaluating AI-generated information, and identifying useful applications in clinical reasoning, education, scientific writing, research, and workflow optimization. Through expert perspectives, real-world examples, and interactive discussion, the session will also address common pitfalls, including hallucinations, bias, privacy concerns, and overreliance on automation. The goal is to provide participants with a practical roadmap for moving from occasional AI use to confident, thoughtful, and responsible integration of AI into professional practice.Precision Solute Control and Dynamic Dosing with CRRTContinuous kidney replacement therapy (CRRT) is often prescribed using fixed effluent targets, yet critically ill patients have rapidly changing metabolic demands, solute loads, and treatment goals. Precision CRRT requires moving beyond a “one-dose-fits-all” approach toward dynamic prescription and real-time adjustment of therapy. In this interactive workshop, participants will learn how to individualize CRRT dose according to clinical objectives, solute kinetics, treatment interruptions, residual kidney function, and evolving metabolic needs. Practical case-based exercises will address clearance of urea and other small solutes, management of severe hyperkalemia and metabolic acidosis, control of sodium and other electrolyte disorders, and strategies for avoiding under- or overdosing. The workshop will also explore how modality, blood flow, dialysate and replacement-fluid rates, predilution, and delivered versus prescribed dose influence solute clearance. Participants will leave with a practical framework for adapting CRRT prescriptions dynamically and safely at the bedside.Social Determinants of Health and Acute Kidney InjuryAcute kidney injury (AKI) is not only a clinical syndrome but also a reflection of social and structural inequities that shape who becomes ill, who receives timely diagnosis, and who survives. Poverty, geography, education, access to clean water and sanitation, healthcare availability, occupational exposures, and delayed referral can all influence the risk, severity, and outcomes of AKI. These determinants are particularly relevant in low- and middle-income settings, where preventable causes of AKI remain common and access to laboratory testing, specialist care, and kidney replacement therapy may be limited. This plenary session will examine how social determinants interact with biological vulnerability and health-system capacity across the AKI continuum—from prevention and early recognition to treatment and recovery. Addressing AKI effectively therefore requires more than advances in diagnostics and therapeutics; it demands equitable health systems, stronger prevention strategies, and policies that reduce barriers to timely kidney care.
Room 101D

19th September 2026 Saturday

Time Session
16:00
17:30
Treatments for ADPKD
Room 105

20th September 2026 Sunday

Time Session
08:20
12:30
Regional Symposium (JSTB / Resilience)
  • Opening
    Wen-Chin LeeTaiwan Speaker
  • Advancing ECCO2R Therapy: Lessons from Vietnam for the Asia-Pacific Region
    Do Ngoc SonVietnam Speaker Advancing ECCO₂R Therapy: Lessons from Vietnam for the Asia-Pacific RegionExtracorporeal carbon dioxide removal (ECCO2R) therapy has been used widely in many ICUs in the world. There has been huge evidence on the effectiveness of the ARDS, COPD exacerbation, bridge to lung transplantation. However, the use of this technology is still limited to center in the developed world. The first 2 ECCO2R cases have been carried out successfully at the Center for Critical Care Medicine of Bach Mai hospital in 2023. There is a lot enthusiasm of technology, especially in early, mild to moderate stages of ARDS, mechanical ventilation complication on the exacerbation of COPD etc.... The problem with these approaches is that there will be more expenses for the patient family and burden for ICU staff. The future of ECCO2R will be individualization and health insurance reimbursement.
    Jin-Shuen ChenTaiwan Moderator
  • The Application of Novel Renal Biomarkers in Clinical and Environmental Nephrology
    Kai-Fan TsaiTaiwan Speaker The Application of Novel Renal Biomarkers in Clinical and Environmental NephrologyOrganophosphate flame retardants (OPFRs) and phthalates are emerging organic pollutants and have “pseudo-persistent” properties in the environment. With widespread utilization in consumer products, OPFRs and phthalates have led to extensive human exposure, and their potential health hazard is a topic of increasing concern. However, the exposure pattern and health effects of OPFRs and phthalates are yet to be investigated in patients with renal disease in Taiwan. Since 2020, the research team at Kaohsiung Chang Gung Memorial Hospital has initiated a study project addressing OPFR and phthalates exposure in the population in Taiwan and its impact on renal diseases. We utilized novel renal biomarkers to detect the subtle renal injury associated with exposure to these environmental pollutants. In our analysis, exposure to these environmental pollutant was universal in the participants, with an overall detection rate of beyond 90%. The associations between OPFR and phthalate exposure and renal disease were identified in patients with chronic kidney disease (CKD), and urinary concentrations of these chemicals were correlated with urinary biomarkers of renal tubular injury and oxidative stress in the CKD population. Our findings highlight the multisystemic health impact of OPFR and phthalate exposure, which warrants particular attention and further investigations, and also underscore the role of novel renal biomarkers in environmental medicine.
    Te-Chao FangTaiwan Moderator
  • Coffee break
  • Developing Next-Generation Dialysis Technologies for Acute Kidney Care and Disaster Preparedness
    Kenichi KokuboJapan Speaker Developing Next-Generation Dialysis Technologies for Acute Kidney Care and Disaster PreparednessAcute kidney care and dialysis during disasters share several important challenges, including limited resources, the need for flexible treatment delivery, and the requirement for safe and stable extracorporeal circulation. From an engineering perspective, next-generation dialysis systems should provide greater flexibility, safety, and resilience under different clinical conditions. In this presentation, I will introduce next-generation dialysis technologies that our group is currently investigating and developing. One of our major projects is a compact dialysis system being developed for home hemodialysis. The system combines dialysate recirculation with adsorption technologies to reduce water and dialysate requirements, together with integrated sensors for remote monitoring of both device operation and patient status. These technologies may also be applicable beyond home hemodialysis. Their low infrastructure requirements and remote monitoring capabilities could facilitate dialysis during disasters, and the same platform could also be adapted for continuous renal replacement therapy (CRRT) in acute kidney care. Another approach under investigation is the delivery of nitric oxide (NO) through the dialysate to improve antithrombogenicity during extracorporeal circulation. Because NO has an extremely short biological half-life, its antithrombotic effects may potentially be localized primarily to the extracorporeal circuit, with limited systemic effects after the blood returns to the patient. This characteristic could be particularly advantageous for patients at high risk of bleeding and may facilitate safer prolonged extracorporeal blood purification. Although these technologies remain under development, they illustrate how engineering approaches can contribute to the future of kidney replacement therapy. Resource-efficient dialysis systems, integrated remote monitoring, and localized antithrombogenic strategies may enable more flexible and safer blood purification across home, acute care, and disaster settings.
    Shih-Hua LinTaiwan Moderator
  • Blood Purification in Disasters: Japan’s Evolving Approach to Hospital Resilience, DMAT Coordination, and ICU-Based Renal Support
    Takeshi MoriguchiJapan Speaker Blood Purification in Disasters: Japan’s Evolving Approach to Hospital Resilience, DMAT Coordination, and ICU-Based Renal Support[Background] Disasters markedly increase the incidence of acute kidney injury (AKI) while simultaneously disrupting the critical lifelines required to deliver renal support. In Japan, most maintenance dialysis patients receive treatment in outpatient clinics rather than large hospitals. During major disasters, including the Noto Peninsula earthquake, the status of affected dialysis facilities and the number of patients requiring treatment were rapidly assessed. Dialysis networks allocated patients based on receiving capacity and arranged transfers outside the affected area when necessary. This demonstrates that disaster renal care relies as much on logistics, information sharing, and regional coordination as it does on dialysis techniques. [Acute Care & Resource Requirements] Acute renal replacement therapy for critically ill patients is typically provided in large hospitals and consumes substantial resources. Patients presenting with crush syndrome, rhabdomyolysis, trauma, shock, sepsis, heat-related illness, or multiple organ failure may require intermittent hemodialysis (IHD), prolonged intermittent renal replacement therapy (PIRRT), or continuous renal replacement therapy (CRRT). These therapies strictly depend on electricity, water, replacement fluids, circuits, filters, catheters, anticoagulants, and trained medical staff. Prompt diagnosis, triage, and timely transfer to hospitals capable of acute blood purification are essential to effective disaster response. [Systems & DMAT Integration] This lecture highlights Japan’s evolving approach to disaster blood purification, developed through repeated experiences with earthquakes, tsunamis, floods, and other emergencies. Particular emphasis is placed on Disaster Base Hospitals, which are expected to maintain emergency functions through earthquake-resistant infrastructure, backup power, water supplies, medical stockpiles, robust communication networks, business continuity planning (BCP), and specialized personnel. Additionally, the role of Disaster Medical Assistance Teams (DMAT) will be discussed in evaluating hospital capabilities, supporting affected facilities, coordinating patient transport, and bridging field medicine with ICU-capable facilities. [Conclusions] From an ICU perspective, disaster blood purification requires a delicate balance between physiological benefit and logistical feasibility. Continuous therapies (CRRT) should be reserved for hemodynamically unstable patients requiring ongoing support, whereas intermittent therapies (IHD/PIRRT) are preferable when rapid correction of hyperkalemia or acidosis is needed, or when resources are limited. Ultimately, blood purification in disasters is a system-dependent form of organ support: a CRRT machine is only as strong as the hospital and regional lifelines behind it.
    Chia-Te LiaoTaiwan Moderator
  • Closing Remarks
    Lung-Chih LiTaiwan Speaker
Room 101C